July 30, 2014. Prostate cancer is a very common cancer and all the current treatments have serious side effects that harm men’s quality of life. The question today is whether the Ablatherm high-intensity focused ultrasound device is safe and effective for the treatment of low-risk, localized prostate cancer. Most men diagnosed with localized, low-risk prostate cancer will not die from prostate cancer, but from something else.
Read More »On Medical Treatments & Products
NCHR Comments Urging FDA to Provide Higher Standards And Upclassify Surgical Mesh For POP And Incontinence
July 30, 2014. On behalf of the National Center for Health Research, I am pleased to have the opportunity to express our views on the proposed order on the reclassification of certain surgical mesh devices and surgical instruments. Our nonprofit Center analyzes and reviews research on a range of treatment issues, and provides objective and understandable information to patients and providers.
Read More »NCHR Testimony to the Obstetrics and Gynecology Devices Panel Morcellation Devices for Uterine Fibroid Removal
July 11, 2014. We need higher standards to ensure that morcellation devices are safe and effective, and that require clinical trials with sufficient numbers of patients to determine the risks of rare but fatal outcomes.
Read More »Statement of Dr. Diana Zuckerman Regarding Antidepressant Warnings
June 19, 2014. A new study claiming to show that antidepressant warnings have backfired has resulted in media quoting researchers’ speculation as if it is fact. It isn’t.
Read More »NCHR Testimony to FDA on VBLOC MAESTRO Device
June 17, 2014. We all know that obesity is often debilitating. The VBLOC device is an innovative way of addressing this important health concern but the question is: how well does it work and does its benefits outweigh its risks?
Read More »